TABLE 4.

MAP2 and IDP1 mRNA half-lives are reduced after Snf1 inhibition when their native promoters are replaced by the ADH2 promoter^a

Genotype	mRNA	Half-life (min) (SD or range)b
WT	ADH2	5.0
ADH2p-MAP2	ADH2	7.1 (6.0–8.2)
ADH2p-IDP1	ADH2	7.1 (0.81)
ADH2p-MAP2	MAP2	9.5 (5–14)
ADH2p-IDP1	IDP1	5.5 (5–6)

^aThe strain names and a description of the Snf1-inhibited mRNA decay experiment are presented in the legend to Fig. 2.

^bHalf-lives were estimated as described in the legend to Table 3 from the data shown in the graphs in Fig. 2B to D and related experiments. The standard deviation (n = 3) or range (n = 2) is shown. The data for ADH2 in a WT strain are from reference 19.